Ascendis Pharma A (ASND) Free Cash Flow Growth (3y) (2015 - 2026)
Ascendis Pharma A (ASND) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
61.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
61.36% |
| Dec 31, 2025 |
3.96% |
| Sep 30, 2025 |
26.54% |
| Jun 30, 2025 |
59.89% |
| Mar 31, 2025 |
52.73% |
| Dec 31, 2024 |
21.44% |
| Sep 30, 2024 |
15.60% |
| Jun 30, 2024 |
21.25% |
| Mar 31, 2024 |
-5.57% |
| Dec 31, 2023 |
32.84% |
| Sep 30, 2023 |
-29.62% |
| Jun 30, 2023 |
-42.63% |
| Mar 31, 2023 |
-32.76% |
| Dec 31, 2022 |
-23.19% |
| Sep 30, 2022 |
-13.88% |
| Jun 30, 2022 |
-173.80% |
| Mar 31, 2022 |
-29.01% |
| Dec 31, 2021 |
-56.37% |
| Sep 30, 2021 |
-24.55% |
| Jun 30, 2021 |
-78.58% |
